Joaquin Duato has been appointed to serve as the Chairman and CEO of Johnson & Johnson.
6 reports, 6 independent
Updated Sep 14
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 6
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Joaquin Duato has been appointed to serve as the Chairman and CEO of Johnson & Johnson.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.J&J and American face product liability suits as Duato leads the company through active litigation.1 source
Joaquin Duato appointed Chairman and CEO of Johnson & Johnson.1 source
Duato commented on the U.S. remaining the largest base.1 source
Keep exploring
The entities involved
-
Joaquin Duato
American corporate executive
Nothing else this week.
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Related events
Coverage
Newest first; wire copies grouped- dailypolitical.com
- yahoo.com
- pmlive.com
- everything-pr.com
- Business WireJohnson & Johnson to Host Investor Conference Call on Third-Quarter Results NEW BRUNSWICK, N.J., September 03, 2025--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for inv
- Insider MonkeyCiti Lifts Johnson & Johnson (JNJ) Price Target to $200 on MedTech Strength Johnson & Johnson (NYSE:JNJ) is one of the top stocks to buy and hold forever. Founded in 1887, the company has built a glo